Stay updated on BIOLUMA Clinical Trial Lung Cancer Biomarkers
Sign up to get notified when there's something new on the BIOLUMA Clinical Trial Lung Cancer Biomarkers page.

Latest updates to the BIOLUMA Clinical Trial Lung Cancer Biomarkers page
- Check5 days agoChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the footer revision number changes from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check12 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and replacing the usual content with an error message. This indicates that the study details are not accessible at the moment.SummaryDifference18%

- Check40 days agoChange DetectedThe page's revision identifier was updated to v3.7.0, replacing the previous v3.6.6 in the revision history.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a newer page version.SummaryDifference0.1%

- Check61 days agoChange DetectedA line noting NIH funding for the study was added: '2016 (U.S. NIH Grant/Contract)'. This provides funding attribution within the study's records.SummaryDifference0.1%

Stay in the know with updates to BIOLUMA Clinical Trial Lung Cancer Biomarkers
Enter your email address, and we'll notify you when there's something new on the BIOLUMA Clinical Trial Lung Cancer Biomarkers page.